Joaquín Gavilá Gregori

4PUBLICATIONS
35CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 01, 2025
Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.

Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa

|Jun 26, 2024
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition.

Leonard Schmiester, Fara Brasó-Maristany, Blanca González-Farré

|Oct 30, 2023
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).

Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori

|Jun 16, 2023
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).

Francisco Ayala de la Peña, Silvia Antolín Novoa, Joaquín Gavilá Gregori

Pageof 1